Member Info for ThinShins

Https:// t. me/+ui2CigP-M39kNDg0

Remove the spaces

Maybe hog maybe time will tell.

Did you see the link I sent to your inbox

Corpse sent you it aswel

Hi Hogbog,

My opinion only but its likely that they're conducting a pilot launch behind the scenes to identify and resolve any teething issues before a full scale launch.

Somebody over on Telegram group had notes from the AGM which stated "A comprehensive launch plan with PR being coordinated with BIO"

Check your inbox also i sent you Telegram link.

Hi Bermondsey,

The fact countdown holds no relevance to Launch.

As explained in their linkedin post from 2weeks ago:

"In support of GO2 for Lung Cancer’s Step Up for 20 Summer Raise Challenge, Cizzle Bio is joining the broader awareness conversation by sharing our own take on 20 lung cancer facts over 20 days."

We're all still waiting for CLIA approval, oh wait that news dropped last Tuesday. The confetti still yet to land.

I too would like access to telegram please, messaged @RickyK on X but not has response

Hi SBT,

Bio have announced it acorss their socials and there was a press release:

https://www.linkedin.com/posts/cizzle-bio-inc_cizzlebio-ciz1b-lungcancer-activity-7472608229106106368-QBZM

https://www.prnewswire.com/news-releases/cizzle-bio-announces-laboratory-validation-of-ciz1b-biomarker-blood-test-for-early-lung-cancer-at-omnihealth-diagnostics-302799735.html

Different article also on https://www.yorkpress.co.uk/news/26202938.cizzle-biotechnology-holdings-lung-cancer-test-goes-usa/

it be nice to get coverage on something non-Yorkshire related *sigh*

@Bufflehead1992 is the Yorkie Post your cup of tea? 😆

https://www.yorkshirepost.co.uk/business/cizzle-biotechnology-york-firm-sees-early-stage-lung-cancer-test-accredited-in-us-8744461

Truly is mindboggling how we reached higher prices on no news and when something material is announced barely any movement.

In terms of PR I could be leading us down the garden path but on Ciz linked in post Kat Arney commented "Great news! Huge congratulations to the whole team 👏👏👏"

Kat Arney - Expert science communicator with two decades of experience as a science writer, public speaker and broadcaster, and author of the popular science books.

Founder of First Create The Media - We get your science. And we bring it to life. First Create The Media is an award-winning communications and marketing agency for the life sciences. We help pioneering biotech innovators get the attention they deserve.

Could be something in the works could be nothing.

https://vimeo.com/1202035393?fl=pl&fe=vl

https://www.***************************/cizzle-biotechnology-us-launch-opens-the-door-to-lung-cancer-test-royalties-video/4121254017

Not quite sure what’s holding the SP back, maybe market wants to see sales revenues

"Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of lung and gastric cancers, today announced the laboratory validation of its proprietary CIZ1B biomarker blood test for early lung cancer at OmniHealth Diagnostics, a CLIA-certified, COLA-accredited clinical laboratory based in Dallas and a member of the Katharos Health family of laboratories. With laboratory validation complete, Cizzle Bio is now finalizing launch readiness activities in preparation for the test's near-term availability to U.S. healthcare providers."

"Completion of the validation process at OmniHealth Diagnostics confirms the test's readiness for use within a U.S. clinical laboratory environment and establishes a foundation for broader access as Cizzle Bio expands validation efforts with additional CLIA-certified laboratory partners."

Https://www.prnewswire.com/news-releases/cizzle-bio-announces-laboratory-validation-of-ciz1b-biomarker-blood-test-for-early-lung-cancer-at-omnihealth-diagnostics-302799735.html

BIO on linkedin.

Cizzle Bio, Inc. is proud to share an important milestone. CIZ1B, our proprietary biomarker blood test for early lung cancer, has completed laboratory validation at OmniHealth Diagnostics.

This marks a key step toward near-term clinical availability and reflects continued progress in our mission to expand access to innovative tools that may help detect lung cancer earlier, when treatment is most effective.

CIZ1B is designed to complement LDCT and other standard diagnostic approaches, helping support clinician decision-making, risk assessment, and diagnostic clarity.

Built on decades of biomarker research, CIZ1B represents Cizzle Bio’s commitment to advancing science into clinical practice.

Detect Early. Save Lives.

Read the full announcement: https://buff.ly/2O91YdM

G.P. Jersey Limited - new post on linkedin

Major milestone achieved for Cizzle Plc – CIZ1B test now approved for clinical use in the USA

We are delighted to share excellent news for Cizzle Biotechnology plc Plc shareholders.

The CIZ1B biomarker test for the early detection of lung cancer has received approval for clinical use in the United States under CLIA accreditation at OmniHealth Diagnostics.

This is a significant regulatory and commercial milestone. It paves the way for the commercial launch of the test with our partner Cizzle Bio, Inc. It allows revenue generation and, most importantly, the opportunity to save lives through earlier detection of lung cancer.

The full details are available in today’s RNS announcement:

https://lnkd.in/gJrdFSVv

This positive development comes at the perfect time, coinciding with Cizzle Plc’s AGM taking place today.

At G.P. Jersey Limited, we are looking forward to the first commercial sales and to the start of saving lives in the USA and beyond.

Hi @Bufflehead1992 , regarding EU and UK, I believe CIZ are targeting UK market after US and then EU and elsewhere.

From the Nov 2025 LOI RNS :

Commenting, Allan Syms, Executive Chairman of Cizzle Biotechnology, said:

"We are now pleased that the UK will be the next phase of our growth plans in making the test available to many patients as soon as possible.

I had some communication late Jan but they couldn't give me a timeline and since then I saw yourself hog and potentially many others were also enquiring so I stopped.

Lets hope BIO's sales launch projections aren't based off of CIZ investors posing as healthcare practitioners enquiring about the tests availability 😆

Thanks for sharing Tedc! somebody call the rocketmen the boosters need priming.

FL commenting on a post on linkedin:

"Cizzle Biotechnology plc Cizzle Bio, Inc. Already have a simple blood test, that is 95% accurate and just about to get accredited in the USA ready for commercial sales. #detectearlysavelives #CIZ"